Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Asset Writedowns and Impairment (2016 - 2026)

Genesco has reported Asset Writedowns and Impairment over the past 17 years, most recently at $478000.0 for Q1 2026.

  • Quarterly results put Asset Writedowns and Impairment at $478000.0 for Q1 2026, down 46.29% from a year ago — trailing twelve months through Jan 2026 was $4.4 million (up 216.04% YoY), and the annual figure for FY2026 was $4.4 million, up 216.04%.
  • Asset Writedowns and Impairment for Q1 2026 was $478000.0 at Genesco, down from $3.9 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for GCO hit a ceiling of $3.9 million in Q4 2025 and a floor of $34000.0 in Q2 2025.
  • Median Asset Writedowns and Impairment over the past 5 years was $276000.0 (2023), compared with a mean of $590428.6.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 90.85% in 2022 and later soared 2782.09% in 2025.
  • Genesco's Asset Writedowns and Impairment stood at $129000.0 in 2022, then fell by 23.26% to $99000.0 in 2023, then surged by 35.35% to $134000.0 in 2024, then soared by 2782.09% to $3.9 million in 2025, then plummeted by 87.62% to $478000.0 in 2026.
  • The last three reported values for Asset Writedowns and Impairment were $478000.0 (Q1 2026), $3.9 million (Q4 2025), and $34000.0 (Q2 2025) per Business Quant data.